FDA issued a Warning Letter to Coral Pharmaceuticals LTD on 10/9/2019 as a result of this inspection.
483 Coral Pharmaceuticals May 2019

483 Coral Pharmaceuticals May 2019

$119 - Not in Stock

FDA investigators audited the Coral Pharmaceuticals - Freeport City, Bahamas facility and issued inspectional observations (via FDA 483) on 24 May 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 24 May 2019
  • Location: Freeport City, Bahamas
  • FEI: 3003301821

Pre-Order Not Available